Perjeta-Herceptin 420 mg (Pertuzumab KIT) 420 MG

Perjeta-Herceptin 420 MG is a pharmaceutical kit containing pertuzumab, used in targeted cancer therapies. This intravenous treatment is designed for specific types of cancer, often in combination with other medications.

Strength

420 MG

Pack Size

14ML & 20ML

Manufacturer / TM Owner

HOFFMANN-LA ROCHE LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Perjeta-Herceptin 420 MG is primarily used in the treatment of certain types of breast cancer. It is often administered as part of a combination therapy to target and inhibit the growth of cancer cells. The medication is intended for use in advanced or metastatic breast cancer cases, where it works alongside other treatments to improve outcomes.

Side Effects

Common effects of Perjeta-Herceptin 420 MG may include infusion reactions, fatigue, and nausea. Some individuals may experience diarrhea, hair loss, or skin reactions. These effects can vary in severity and may require monitoring by a healthcare professional.

Precautions & Warnings

Perjeta-Herceptin 420 MG should be handled with care, as it is intended for intravenous administration. It is important to follow proper storage and handling guidelines to maintain its efficacy. Patients should be monitored for any adverse reactions, and the medication should be used under the supervision of a healthcare provider.

Avoid Interactions

Perjeta-Herceptin 420 MG may interact with other medications, particularly those that affect the immune system or are used in cancer treatments. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of the treatment.

References

Frequently Asked Questions

Perjeta-Herceptin 420 MG is used in the treatment of certain types of breast cancer, often in combination with other medications.

Perjeta-Herceptin 420 MG is administered intravenously, typically in a clinical setting under the supervision of a healthcare professional.

Common side effects may include infusion reactions, fatigue, nausea, diarrhea, hair loss, and skin reactions.

Perjeta-Herceptin 420 MG may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Proper storage, handling, and monitoring by a healthcare professional are essential when using Perjeta-Herceptin 420 MG.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.